Regorafenib

Definition: Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase (RTK). Regorafenib shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition. source: Wikipedia

ID

777416007

Name

Regorafenib

Previous ID

703808002

ID date

6 Feb 2023